What’s the Middleman Doing? The Need for PBM Transparency | Integra X Files

Ryan Oftebro, PharmD, FACA, CEO of independent Kelley-Ross Pharmacy Group, joins us for an open conversation about pharmacy benefit managers (PBM) fresh off his testimony on Capitol Hill. Oftebro spoke to the Senate Committee on Commerce, Science, and Transportation, during a hearing addressing how the “Pharmacy Benefit Manager Transparency Act” will bring transparency into PBM business practices and prohibit unfair or deceptive PBM conduct.